Visfatin levels in hormonally inactive adrenal adenoma and their association with metabolic parameters

Twenty-four-hour ambulatory blood pressure monitoring and carotid artery intima-media thickness (CIMT)measurements were performed.Results: The frequencies of diabetes mellitus and hypertension were found to be statistically higher in the adrenal adenoma group.Although the values of mean fasting glucose, insulin, HOMA-IR levels, and the mean, maximum, minimum, delta systolic, and diastolicblood pressures were established to be higher in the adrenal adenoma group, the differences were not found to be statistically significant.Mean high-sensitive C-reactive protein, visfatin levels, and CIMT were seen to be significantly higher in the adenoma group.Conclusion: Cardiometabolic risk factors as well as the visfatin levels were established to be higher in patients with adrenal adenoma.Elevated visfatin levels might play a role in the development and metabolic process of adrenal adenoma.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/aim: In parallel with increased frequency and higher quality of imaging techniques, the prevalence of adrenal adenomahas gradually increased.

📊

Key Findings & Data:Therefore, the present study was performed with an aim to evaluate visfatin levels and cardiometabolic riskfactors in patients with adrenal adenoma.Materials and methods: Thirty patients recently diagnosed with adrenal adenoma along with 30 healthy participants were studied in atertiary healthcare center.

💡

Conclusion & Impact:Twenty-four-hour ambulatory blood pressure monitoring and carotid artery intima-media thickness (CIMT)measurements were performed.Results: The frequencies of diabetes mellitus and hypertension were found to be statistically higher in the adrenal adenoma group.Although the values of mean fasting glucose, insulin, HOMA-IR levels, and the mean, maximum, minimum, delta systolic, and diastolicblood pressures were established to be higher in the adrenal adenoma group, the differences were not found to be statistically significant.Mean high-sensitive C-reactive protein, visfatin levels, and CIMT were seen to be significantly higher in the adenoma group.Conclusion: Cardiometabolic risk factors as well as the visfatin levels were established to be higher in patients with adrenal adenoma.Elevated visfatin levels might play a role in the development and metabolic process of adrenal adenoma.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background/aim: In parallel with increased frequency and higher quality of imaging techniques, the prevalence of adrenal adenomahas gradually increased. However, despite the growing incidence, the metabolic and tumorigenesis processes involved in its etiology arestill unclear. Although visfatin has been reported to be associated with inflammation and tumorigenesis, its role in adrenal adenoma hasnot yet been investigated. Therefore, the present study was performed with an aim to evaluate visfatin levels and cardiometabolic riskfactors in patients with adrenal adenoma.Materials and methods: Thirty patients recently diagnosed with adrenal adenoma along with 30 healthy participants were studied in atertiary healthcare center. Twenty-four-hour ambulatory blood pressure monitoring and carotid artery intima-media thickness (CIMT)measurements were performed.Results: The frequencies of diabetes mellitus and hypertension were found to be statistically higher in the adrenal adenoma group.Although the values of mean fasting glucose, insulin, HOMA-IR levels, and the mean, maximum, minimum, delta systolic, and diastolicblood pressures were established to be higher in the adrenal adenoma group, the differences were not found to be statistically significant.Mean high-sensitive C-reactive protein, visfatin levels, and CIMT were seen to be significantly higher in the adenoma group.Conclusion: Cardiometabolic risk factors as well as the visfatin levels were established to be higher in patients with adrenal adenoma.Elevated visfatin levels might play a role in the development and metabolic process of adrenal adenoma.

🔖

Cite This Article

ATAOĞLU, E., KOLDAŞ, M., ÇAKIR, E., YENİGÜN, M., AHBAB, S., DÖVENTAŞ, Y. E., ATASOY, A. (2022). Visfatin levels in hormonally inactive adrenal adenoma and their association with metabolic parameters. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 3, 548–553. https://ajindex.com/articles/610305

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14: 1431-1437.
Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178: 1748-1758.
Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007; 23: 164-170.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
Tuna MM, Imga NN, Dogan BA, Yilmaz FM, Topcuoglu C, Akbaba G, Berker D, Guler S. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest 2014; 37: 765-768.
Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T, Hadjidakis D, Raptis SA. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism 2010; 59: 1435-1441.
Yener S, Genc S, Akinci B, Secil M, Demir T, Comlekci A, Ertilav S, Yesil S. Carotid intima media thickness is increased and associated with morning cortisol in subjects with nonfunctioning adrenal incidentaloma. Endocrine 2009; 35: 365- 370. Comlekci A, Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L, Bayraktar F, Yesil S, Eraslan S. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010; 37: 40-46.
Arruda M, Mello Ribeiro Cavalari E, Pessoa de Paula M, Fernandes Cordeiro de Morais F, Furtado Bilro G, Alves Coelho MC, de Oliveira E Silva de Morais NA, Choeri D, Moraes A, Vieira Neto L. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J Hum Hypertens 2017; 32: 3-11.
Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.